REFERENCES
H. Ohnishi, T. H. Lin, I. Nakajima, and T. M. Chu. Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity. Tumour Biol. 12:99-110 (1991).
Y. Tanaka, T. Tanaka, and H. Ishitsuka. Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants. Cancer Res. 49:5935-5939 (1989).
T. Jimbo, T. Akimoto, and A. Tohgo. Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice. Cancer Immunol. Immunother. 40:10-16 (1995).
K. Nakata, S. Kashimoto, H. Yoshida, T. Oku, and S. Nakamura. Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin. Cancer Res. 48:584-588 (1988).
K. Lundholm, J. Gelin, A. Hyltander, C. Leonnroth, R. Sandstreom, and G. Svaninger. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 54:5602-5606 (1994).
L. Yuan, M. Kobayashi, Y. Kuramitsu, Y. Li, K. Matsushita, and M. Hosokawa. Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor beta in rats bearing KDH-8 hepatoma cells. Cancer Immunol. Immunother. 45:71-76 (1997).
S. Nonoyama and H. D. Ochs. Immune deficiency in SCID mice. Int. Rev. Immunol. 13:289-300 (1996).
S. Shimizu, Y. Nishikawa, K. Kuroda, S. Takagi, K. Kozaki, S. Hyuga, S. Saga, and M. Matsuyama. Involvement of transforming growth factor beta 1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res. 56:3366-3370 (1996).
M. Tanaka, H. Miyazaki, Y. Takeda, and S. Takeo. Detection of serum cytokine levels in experimental cancer cachexia of colon 26 adenocarcinoma-bearing mice, Cancer Lett. 72:65-70 (1993).
M. Stoeck, S. Miescher, H. R. MacDonald, and V. Von-Fliedner. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line. J. Cell Physiol. 141:65-73 (1989).
M. Ogino, H. Hisatomi, and M. Hanazono. Effectiveness of indomethacin as an antitumor agent in colon 26-bearing conventional and nude mice, and telomerase activity in the tumors. Exp. Anim. 48:15-21 (1999).
P. I. Homem-de-Bittencourt-Junior, V. Pontieri, R. Curi, and O. V. Lopes. Effects of aspirin-like drugs on Walker 256 tumor growth and cachexia in rats. Braz. J. Med. Biol. Res. 22:1039-1042 (1989).
S. M. Mahony, S. A. Beck, and M. J. Tisdale. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour. Br. J. Cancer 57:385-389 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsushita, R., Hattori, K., Hayashi, K. et al. Synergistic Effect of Indomethacin and Bleomycin on Tumor Growth Produced by Activating Antitumor Immunity. Pharm Res 18, 243–245 (2001). https://doi.org/10.1023/A:1011048905732
Issue Date:
DOI: https://doi.org/10.1023/A:1011048905732